<div><div></div><div><span><p><strong><span>Apog announced that Andrew Gottesdiener, M.D. and Peter Harwin will resign from the board effective May 11, 2026.</span></strong></p><div><table><tbody><tr><td><span>Individual</span></td><td><span>Andrew Gottesdiener, M.D.</span></td><td><span>Peter Harwin</span></td></tr><tr><td><span>Role</span></td><td><span>Director</span></td><td><span>Director</span></td></tr><tr><td><span>Type of Change</span></td><td><span>Resignation</span></td><td><span>Resignation</span></td></tr><tr><td><span>Effective Date</span></td><td><span>May 11, 2026</span></td><td><span>May 11, 2026</span></td></tr><tr><td><span>Reason</span></td><td><span>Not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices</span></td><td><span>Not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices</span></td></tr><tr><td><span>Replacement Info</span></td><td><span>Not disclosed</span></td><td><span>Not disclosed</span></td></tr><tr><td><span>Background Details</span></td><td><span>Not disclosed</span></td><td><span>Not disclosed</span></td></tr><tr><td><span>Board/Committee Role Changes</span></td><td><span>Not disclosed</span></td><td><span>Not disclosed</span></td></tr></tbody></table></div><p><span>Original SEC Filing: </span>Apogee Therapeutics, Inc. [ APGE ] - 8-K - Apr. 24, 2026</p><section><b><span class="heading-aHOVUrmQ">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

APGE

IBBQ

SBIO

LABU

<p>Apog announced the resignations of Andrew Gottesdiener, M.D. and Peter Harwin from its board, effective May 11, 2026. The resignations are not due to any disagreements with the company regarding its operations, policies, or practices. Replacement information has not been disclosed. This announcement was filed with the SEC as part of Apogee Therapeutics, Inc.'s 8-K on April 24, 2026.</p>

Apog appoints resignations of Andrew Gottesdiener and Peter Harwin from board